Why Small Molecule Thinking Will Fail You in the Biosimilar Era
Small-molecule thinking is about to hit a wall.
For decades, the industrys playbook for biosimilars has been shaped by the logic of generics: if the active ingredient is the same, the rest should follow. But the biosimilar era doesnt reward that kind o…
Why Small Molecule Thinking Will Fail You in the Biosimilar Era Read Post »
